GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Float Percentage Of Total Shares Outstanding

Medicure (TSXV:MPH) Float Percentage Of Total Shares Outstanding : 48.53% (As of Jun. 01, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medicure's float shares is 5.07 Mil. Medicure's total shares outstanding is 10.44 Mil. Medicure's float percentage of total shares outstanding is 48.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medicure's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medicure's Institutional Ownership is 2.44%.


Medicure Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Medicure's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.07/10.44
=48.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicure (TSXV:MPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Executives
Albert David Friesen Director, Senior Officer

Medicure (TSXV:MPH) Headlines

No Headlines